Abstract
Mitochondrial respiratory chain disorders are a group of clinically and genetically heterogeneous diseases. Several mitochondrial (mt)DNA point mutations are responsible for common mitochondrial diseases. These pathogenic mtDNA point mutations are usually heteroplasmic. Molecular diagnosis of the disease requires both qualitative detection of the mutation and quantitative analysis of the mutant heteroplasmy. In this report, two methods based on real-time quantitative polymerase chain reaction (PCR) analysis are used. The first method utilizes wild-type or mutant sequence-specific TaqMan® probe, which is labeled with a fluorescent reporter molecule at the 5′-end of the oligonucleotide probe and a quencher at the 3′-end of the probe. The second method utilizes sequence-specific primers to amplify the wild-type or mutant sequence followed by SYBR® green detection of PCR products. Both methods allow simultaneous detection and quantification of the mutant mtDNA. In this chapter, we describe the detailed procedures regarding the application of fluorescent probes, and real time quantitative PCR in the molecular diagnosis of mitochondrial DNA disorders.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Anderson, S., Bankier, A. T., Barrell, B. G., et al. (1981) Sequence and organization of the human mitochondrial genome. Nature 290, 457–465.
Bai, R. K. and Wong, L. J. (2004) Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach. Clin. Chem. 50, 996–1001.
Johns, D. R. (1996) Mitochondrial DNA and disease. N. Engl. J. Med. 333, 638–644.
Lahiri, D. and Nurnberger, Jr. J. (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19, 5444.
Liang, M. H. and Wong, L.-J. C. (1998) Yield of mtDNA mutation analysis in 2000 patients. Am. J. Med. Genet. 77, 385–400.
Newton, C. R., Graham, A., Heptinstall, L. E., et al. (1989) Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17, 2503–2516.
Sambrook, J., and Russell, D.W. (2001) Molecular Cloning—Laboratory Manuals, Vol. 3, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
Shanske, S. and Wong, L.-J. C. (2004) Molecular analysis for mitochondrial DNA disorders. Mitochondrion 4, 403–415.
Smeitink, J., van den Heuvel, L., and DiMauro, S. (2001) The genetics and pathology of oxidative phosphorylation. Nature Rev. Genet. 2, 342–352.
Wallace, D. C. (1992) Disease of mitochondrial DNA. Annu. Rev. Biochem. 61, 1175–1212.
Wong, L.-J. C. and Lam, C. (1997) Alternative, noninvasive tissues for quantitative screening of mutant mitochondrial DNA. Clin. Chem. 43, 1241–1243.
Wong, L.-J. C. and Senadheera, D. (1997) Direct detection of multiple point mutations in mitochondrial DNA. Clin. Chem. 43, 1857–1861.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Wong, LJ.C., Bai, RK. (2006). Real-Time Quantitative Polymerase Chain Reaction Analysis of Mitochondrial DNA Point Mutation. In: Didenko, V.V. (eds) Fluorescent Energy Transfer Nucleic Acid Probes. Methods in Molecular Biology™, vol 335. Humana Press. https://doi.org/10.1385/1-59745-069-3:187
Download citation
DOI: https://doi.org/10.1385/1-59745-069-3:187
Publisher Name: Humana Press
Print ISBN: 978-1-58829-380-0
Online ISBN: 978-1-59745-069-0
eBook Packages: Springer Protocols